The open index of psychedelic research

Chlorogenic Acid Attenuates Schizophrenia-Like Behavioral Deficits and Neuroinflammation in a Ketamine-Induced Mouse Model

Murtaza A, Altaf R, Abbas M

Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

Intramuscular Ketamine for Suicidal Patients in the Evanston Hospital Emergency Department for Suicidal Distress

Response to "Methodological Caveats in Evaluating Perioperative Esketamine for Postoperative Pain Sensitivity: A Comment on the Study by Chen et al" [Response to Letter].

Wu Y, Chen Y

Clinical correlates of non-responders to ketamine in terms of self-assessed life engagement among treatment-resistant depression patients.

Walaszek M, Cubała WJ, Pastuszak K +1

U.S. Ketamine Treatment Access Dataset, 2026

KetamineFinder

Evaluating clinical characteristics and outcomes associated with body stuffers presenting to the emergency department: a five-year retrospective analysis from a United States poison center.

Rabotnick J, Rabotnick MH, King A +1

Changes in Glutathione and Homocysteine Concentrations in Treatment-Resistant Depression After Electroconvulsive Therapy.

Permoda-Pachuta A, Ziemecki P, Dorszewska J +2

Dataset for the study: Intraoperative analgesic requirements in dogs receiving retro-mammillary or erector spinae plane blocks for thoracolumbar or lumbar hemilaminectomy: a single-center retrospective cohort study

Cavalcanti-McKenzie, Mariana, Moura, Raiane A, Portela, Diego A

Psychedelic 4-AcO-DMT attenuated looming-induced freezing behaviors by activating PrL <sup>CaMKIIα</sup> neurons in mice.

Xia K, Wang Y, Liu J +3

A Two-Threshold Model of Psilocybin Response Explains Variability in Psychedelic-Assisted Therapy for Treatment-Resistant Depression

Castillo-Sánchez JI

MDMA-Assisted Therapy May Decrease PTSD Symptoms, Dissociation, Depression, and Functional Disability: A Systematic Review and Meta-Analysis.

Green WM, Raut SB, James FLJ +4

A national approach in a European context: Multidisciplinary and multiprofessional recommendations on the clinical use of psychedelic substances.

Seybert C, Pires AM, Madeira L +5

Craving Reduction and Smoking Outcomes in Psilocybin-Assisted and Standard Cessation Care.

Strandberg L, Fernandes TP, Shoshina II +2

Psilocybin selectively suppresses novelty-induced grooming via 5-HT2B receptors: A microstructure analysis in Wistar rats.

Seillier A, El Dannan GI, Seillier L

Ketamine-Induced Dissociation as an Ethical Signal, Not a Side Effect: Context as the Determinant of Clinical Duties Under Beneficence and Non-maleficence.

Moon G, Noto J, Shuler Z +1

Why taking the trip out of psychedelic medicine is a mistake.

Heller J, Hendlin YH

Caffeine-induced ego-confrontation during rest

Gal C

Anesthetic recovery following a midazolam-containing co-induction protocol in horses undergoing total intravenous anesthesia.

Claudino JA, Avelar PHS, Rosa MCB +2

Toward an interdisciplinary mind science of advanced meditation.

Lieberman JM, Sacchet MD

A Developmental Stability Theory of Predictive Hierarchies: Why Some Perceptual Architectures Remain Stable Under Perturbation

Bukhari S

Mystical but not challenging experiences predict symptom improvement after psilocybin for treatment-resistant OCD.

Shnayder S, Agin-Liebes G, Hubert TJ +5

Psilocybin for Treatment of OCD-2

Deconstruction of lysergic acid diethylamide.

Basargin AG, Domokos A, Hennessey JJ +17